Quanta has found that one of the most prominent topics in current bio-tech and pharmaceutical industry news is the discovery of Fisetin. Fisetin is a chemical that is found in strawberries and other fruits. Research has shown that this flavonoid has been linked to enhancing long term memory. If the substance can be made into a drug, it will be useful particularly to those aged 60 and over. This is because this age group is more susceptible to memory loss and other forms of dementia. It seems the bio-tech and Pharmaceutical industry have accepted that the chemical is safe enough for consumption in an oral form.
According to experts in the field, Fisetin both prevents brain cells from dying and promotes the growth of connections between nerve cell. It is also worth mentioning that Fisetin has been discovered in some vegetables as well. Other prominent news in bio-tech and pharmaceutical industry include the discovery that scientists have discovered that proteins can act as a fuel for cells. They have stated that protein is perhaps the most important organic fuel for keeping a cell alive. However, these protein fuel cells have not yet been developed in such a way that they can be used topically.
In future, they will prove particularly useful in the sewage and waste management industry, because they can be used to breakdown organic waste matter. Protein fuel cells can also be used to generate substantial amounts of electricity and as such, the industry believes that it may be a future source for energy. The bio-tech and pharmaceutical industry have also revealed that PNS studies are now able to demonstrate why organs fail in the event of massive body trauma. According to the studies, immediately after a traumatic incident, the body organs are not able to adapt themselves to function as normal. As a result of these findings, the bio-tech and pharmaceutical industry has revealed that top experts in the field are now currently working on solving post-trauma organ failure.
They have also discovered revolutionary bio chemical methods which can be effective in solving the problem. According to Proceedings of the National Academy of Sciences (PNAS) publications, experts are coming up with innovative ways for changing emergency room procedures and set-ups and are also creating new frameworks for the quicker diagnosis of organ failure caused by post trauma. Furthermore, the development of specific drugs to tackle the problem is a distinct possibility.
Stephen Trigg is the CEO of Quanta Consultancy Services, the leader provider of Recruitment Company.